Stendra (Avanafil)

$190.00$6,500.00

Avanafil is a PDE5 inhibitor approved for erectile dysfunction by the FDA on April 27, 2012 and by EMA on June 21, 2013. Avanafil is known by the trademark names Stendra and Spedra. It was invented at Mitsubishi Tanabe Pharma, formerly known as Tanabe Seiyaku Co.
Molar mass: 483.951 g/mol
Trade name: Stendra
PubChem CID: 9869929
IUPHAR ID: 7448
Clear
SKU: N/A Category:
WhatsApp chat